Related references
Note: Only part of the references are listed.Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma
Yoshie Yoshikawa et al.
CANCER SCIENCE (2012)
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Michele Carbone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers
Mohamed H. Abdel-Rahman et al.
JOURNAL OF MEDICAL GENETICS (2011)
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
Matthew Bott et al.
NATURE GENETICS (2011)
Germline mutations in BAP1 predispose to melanocytic tumors
Thomas Wiesner et al.
NATURE GENETICS (2011)
Germline BAP1 mutations predispose to malignant mesothelioma
Joseph R. Testa et al.
NATURE GENETICS (2011)
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
J. William Harbour et al.
SCIENCE (2010)
Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches
Marco Tomasetti et al.
Current Molecular Pharmacology (2010)
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Mathew E. Sowa et al.
CELL (2009)
Malignant pleural mesothelioma: current treatments and emerging drugs
Carmen Belli et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1
Yuichi J. Machida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1
Shahram Misaghi et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Functional inactivation of NF2/merlin in human mesothelioma
Claudio Thurneysen et al.
LUNG CANCER (2009)
Surgical Options in Malignant Pleural Mesothelioma: Extrapleural Pneumonectomy or Pleurectomy/Decortication
Raja M. Flores
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2009)
BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization
Karen H. Ventii et al.
CANCER RESEARCH (2008)
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients
Raja M. Flores et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
Malignant mesothelioma
Alastair J. Moore et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Cancer proliferation gene discovery through functional Genomics
Michael R. Schlabach et al.
SCIENCE (2008)
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
Sanja Dacic et al.
VIRCHOWS ARCHIV (2008)
Genome-scale RNAi profiling of cell division in human tissue culture cells
Ralf Kittler et al.
NATURE CELL BIOLOGY (2007)
Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center
Raja M. Flores et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Multimodatity approach in management of malignant pleural mesothelioma
S Neragi-Miandoab
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2006)
Pleural mesothelioma: little evidence, still time to do trials
T Treasure et al.
LANCET (2004)
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer
B He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains
DL Mallery et al.
EMBO JOURNAL (2002)
Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma
GJ Gordon et al.
CARCINOGENESIS (2002)
Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma
GL Ceresoli et al.
LUNG CANCER (2001)
Share Paper
